Secukinumab
Monoclonal antibody against IL-17
Secukinumab
Secukinumab, sold under the brand name Cosentyx among others, is a human IgG1κ monoclonal antibody used for the treatment of psoriasis, ankylosing spondylitis, psoriatic arthritis, and hidradenitis suppurativa. It binds to the protein interleukin (IL)-17A and is marketed by Novartis.
Read on Wikipedia · Image Raimond Spekking, CC BY-SA 4.0
-0522.jpg){kind=link}
Open boosters, collect cards and trade them. Free to play.
Play for free